Hikma and Civica Rx have struck a five-year supply deal that will see the UK-based firm manufacture and supply the US outfit with 14 essential sterile injectables, as part of Civica’s mission to supply drugs that are often in short supply in US hospitals.
Under the agreement, Hikma will produce the injectables for Civica as a private label distributor, using Hikma’s abbreviated new drug...





